Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Zurix Sciences | Premium Research CompoundsYou need to enable JavaScript to run this app.Made with Emergent
Metabolic Disease Model Research Laboratory studies investigate AOD9604 in metabolic contexts: Obesity Models: Research in diet-induced obesity examining fat mass reduction mechanisms Insulin Resistance: Studies assessing metabolic improvements without insulin antagonism Hepatic Steatosis: Investigation of liver fat reduction through enhanced peripheral lipolysis Metabolic Syndrome: Research on multiple metabolic parameter improvements Comparison to GH: Assessment of metabolic benefits without GH receptor-mediated side effects Experimental protocols evaluate whether selective lipolytic stimulation provides metabolic benefits with improved safety profile
GLP-1 appetite suppression is stronger and glucagon effects continue to scale with dose
These connective tissues heal slowly, so expect 6-12 weeks of treatment for significant injuries
US$ 28.20
US$ 29.19
US$ 24.68
US$ 24.46